Kaleido Biosciences Inc. (KLDO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts KLDO Hot Sheet
Join SI Premium – FREE
Kaleido Biosciences Inc. (NASDAQ: KLDO) reported Q1 EPS of ($0.64), in-line with the analyst estimate of ($0.64).
For earnings history and earnings-related data on Kaleido Biosciences Inc. (KLDO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
